Angiodynamics (ANGO) Research & Development (2010 - 2026)

Angiodynamics' Research & Development history runs 17 years deep, the most recent figure standing at $92.1 million for Q2 2026.

• Quarterly Research & Development rose 1298.06% year-over-year to $92.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $132.3 million (up 106.89% YoY) and the FY2026 annual result came in at $113.4 million, up 332.47% from the prior year.
• Research & Development was $92.1 million for Q2 2026 at Angiodynamics, up from $7.1 million in the prior quarter.
• Across five years, Research & Development topped out at $92.1 million in Q2 2026 and bottomed at -$10.5 million in Q2 2024.
• A 5-year average of $21.5 million and a median of $14.5 million in 2022 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2024 — Research & Development tumbled 233.49% — and 2026, when it soared 1298.06%.
• Angiodynamics' Research & Development stood at $6.8 million in 2022, then climbed by 26.62% to $8.7 million in 2023, then jumped by 195.55% to $25.6 million in 2024, then increased by 4.38% to $26.7 million in 2025, then soared by 244.92% to $92.1 million in 2026.
• Business Quant data shows ANGO's Research & Development at $92.1 million in Q2 2026, $7.1 million in Q1 2026, and $26.7 million in Q4 2025.